Terms: = Prostate cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI
7798 results:
1. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Carmignani L; De Cobelli O; Mischinger J; Ahyai S; Karakiewicz PI
World J Urol; 2024 Apr; 42(1):269. PubMed ID: 38679642
[TBL] [Abstract] [Full Text] [Related]
2. Breakthrough electroneutron multi-response miniature dosimetry/spectrometry in medical accelerator.
Sohrabi M; Malekitakbolagh M; Nedaei HA
Sci Rep; 2024 Apr; 14(1):9557. PubMed ID: 38664481
[TBL] [Abstract] [Full Text] [Related]
3. Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using
Muralidhar A; Hernandez R; Morris ZS; Comas Rojas H; Bio Idrissou M; Weichert JP; McNeel DG
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38663936
[TBL] [Abstract] [Full Text] [Related]
4. [Study on the efficacy and complications of patients undergoing radical surgery and radical radiotherapy for localized prostate cancer].
Shi XQ; Wang SH; Liu Z; Lu LW; Xu S; Fu D; Cheng W
Zhonghua Nan Ke Xue; 2023 Oct; 29(10):910-915. PubMed ID: 38639661
[TBL] [Abstract] [Full Text] [Related]
5. Unmet supportive care needs among cancer patients: exploring cancer entity-specific needs and associated factors.
Springer F; Mehnert-Theuerkauf A; Gebhardt C; Stolzenburg JU; Briest S
J Cancer Res Clin Oncol; 2024 Apr; 150(4):190. PubMed ID: 38607426
[TBL] [Abstract] [Full Text] [Related]
6. [The mediating effect of coping style between illness perception and fear of cancer recurrence in patients undergoing radical prostatectomy].
Yan QQ; Yao X; Liu YC; Zhou JR; Cai J; Wu ZG; Jiang HH; Li HY
Zhonghua Nan Ke Xue; 2023 Jun; 29(6):511-517. PubMed ID: 38602723
[TBL] [Abstract] [Full Text] [Related]
7. Provider Perceptions of an Electronic Health Record prostate cancer Screening Tool.
Carlsson SV; Preston M; Vickers A; Malhotra D; Ehdaie B; Healey M; Kibel AS
Appl Clin Inform; 2024 Mar; 15(2):282-294. PubMed ID: 38599619
[TBL] [Abstract] [Full Text] [Related]
8. Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study.
Hietikko R; Mirtti T; Kilpeläinen TP; Tolonen T; Räisänen-Sokolowski A; Nordling S; Hannus J; Laurila M; Taari K; Tammela TLJ; Autio R; Natunen K; Auvinen A; Rannikko A
World J Urol; 2024 Apr; 42(1):217. PubMed ID: 38581590
[TBL] [Abstract] [Full Text] [Related]
9. Prediction of false-positive PI-RADS 5 lesions on prostate multiparametric MRI: development and internal validation of a clinical-radiological characteristics based nomogram.
Cheng Y; Fan B; Fu Y; Yin H; Lu J; Li D; Li X; Qiu X; Guo H
BMC Urol; 2024 Apr; 24(1):76. PubMed ID: 38566091
[TBL] [Abstract] [Full Text] [Related]
10. Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Bührer E; D'Haese D; Daugaard G; de Wit R; Albany C; Tryakin A; Fizazi K; Stahl O; Gietema JA; De Giorgi U; Cafferty FH; Hansen AR; Tandstad T; Huddart RA; Necchi A; Sweeney CJ; Garcia-Del-Muro X; Heng DYC; Lorch A; Chovanec M; Winquist E; Grimison P; Feldman DR; Terbuch A; Hentrich M; Bokemeyer C; Negaard H; Fankhauser C; Shamash J; Vaughn DJ; Sternberg CN; Heidenreich A; Collette L; Gillessen S; Beyer J
Eur J Cancer; 2024 May; 202():114042. PubMed ID: 38564927
[TBL] [Abstract] [Full Text] [Related]
11. Optimizing PSMA scintigraphy for resource limited settings - a retrospective comparative study.
Kolade OU; Brink A; Ayeni AO; More S; Holness J
Cancer Imaging; 2024 Apr; 24(1):46. PubMed ID: 38556864
[TBL] [Abstract] [Full Text] [Related]
12. Decision regret of cancer patients after radiotherapy: results from a cross-sectional observational study at a large tertiary cancer center in Germany.
Rühle A; Wieland L; Hinz A; Mehnert-Theuerkauf A; Nicolay NH; Seidel C
J Cancer Res Clin Oncol; 2024 Mar; 150(3):167. PubMed ID: 38546873
[TBL] [Abstract] [Full Text] [Related]
13. Dietary and Smoking Acrylamide and prostate cancer Risk: CAPLIFE Study.
Lozano-Lorca M; Muñoz-Bravo C; Barrios-Rodríguez R; Castillo-Hermoso MÁ; Kouiti M; González-Palacios Torres C; Jiménez-Moleón JJ; Olmedo-Requena R
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542747
[TBL] [Abstract] [Full Text] [Related]
14. The design, synthesis and bioactivity evaluation of novel androgen receptor degraders based on hydrophobic tagging.
Sun Y; Wang H; Li Y; Li Z; Mao Z; Zhang M; Shao Y; Ye J; Li D; Shan L
Bioorg Chem; 2024 May; 146():107309. PubMed ID: 38537338
[TBL] [Abstract] [Full Text] [Related]
15. Minimally invasive cytoreductive radical prostatectomy, exploring the safety and feasibility of a single-port or multi-port robotic platform.
Lama DJ; Thomas K; Vernez SL; Okunowo O; Lau CS; Yuh BE
BMC Urol; 2024 Mar; 24(1):72. PubMed ID: 38532371
[TBL] [Abstract] [Full Text] [Related]
16. The feasibility and acceptability of an app-based intervention with brief behavioural support (APPROACH) to promote brisk walking in people diagnosed with breast, prostate and colorectal cancer in the UK.
Lally P; Kennedy F; Smith S; Beeken RJ; Buck C; Thomas C; Counsell N; Wyld L; Martin C; Williams S; Roberts A; Greenfield DM; Gath J; Potts HWW; Latimer N; Smith L; Fisher A
Cancer Med; 2024 Mar; 13(6):e7124. PubMed ID: 38529687
[TBL] [Abstract] [Full Text] [Related]
17. Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging study.
Pruis IJ; van Doormaal PJ; Balvers RK; van den Bent MJ; Harteveld AA; de Jong LC; Konijnenberg MW; Segbers M; Valkema R; Verburg FA; Smits M; Veldhuijzen van Zanten SEM
EBioMedicine; 2024 Apr; 102():105068. PubMed ID: 38518652
[TBL] [Abstract] [Full Text] [Related]
18. ReHoGCNES-MDA: prediction of miRNA-disease associations using homogenous graph convolutional networks based on regular graph with random edge sampler.
Zhang Y; Chu Y; Lin S; Xiong Y; Wei DQ
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38517693
[TBL] [Abstract] [Full Text] [Related]
19. A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients.
Lilly MB; Wu C; Ke Y; Chen WP; Soloff AC; Armeson K; Yokoyama NN; Li X; Song L; Yuan Y; McLaren CE; Zi X
Clin Transl Med; 2024 Mar; 14(3):e1627. PubMed ID: 38515274
[TBL] [Abstract] [Full Text] [Related]
20. The association between zinc and prostate cancer development: A systematic review and meta-analysis.
Shahrokhi Nejad S; Golzari Z; Zangiabadian M; Salehi Amniyeh Khozani AA; Ebrahimi R; Nejadghaderi SA; Aletaha A
PLoS One; 2024; 19(3):e0299398. PubMed ID: 38507438
[TBL] [Abstract] [Full Text] [Related]
[Next]
